Adeoye Y. Olukotun - Mar 3, 2023 Form 4 Insider Report for ARROWHEAD PHARMACEUTICALS, INC. (ARWR)

Role
Director
Signature
/s/Adeoye Olukotun
Stock symbol
ARWR
Transactions as of
Mar 3, 2023
Transactions value $
-$370,578
Form type
4
Date filed
3/6/2023, 05:04 PM
Previous filing
Jan 11, 2023
Next filing
May 10, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ARWR Common Stock Sale -$371K -11.4K -59.06% $32.65 7.87K Mar 3, 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported on Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.36 to $32.88, inclusive. The reporting person undertakes to provide to Arrowhead Pharmaceuticals, Inc., any security holder of Arrowhead Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote of this Form 4.
F2 Includes previously reported shares of common stock underlying Restricted Stock Units granted to the Reporting person which are subject to certain vesting conditions.